Takeda Pharmaceutical (TAK) Work In Process (2019)
Takeda Pharmaceutical (TAK) posted quarterly Work In Process of $286.7 million for Q1 2019.
Takeda Pharmaceutical (TAK) Work In Process (2019) Analysis & Trends
Takeda Pharmaceutical's Work In Process history runs 1 years deep, the most recent figure standing at $286.7 million for Q1 2019.
- In Q1 2019, Work In Process changed N/A year-over-year to $286.7 million; the TTM figure through Mar 2019 stood at $286.7 million (changed N/A YoY), while the FY2019 annual figure was $286.7 million, changed N/A from the prior year.
- Work In Process for Q1 2019 stood at $286.7 million.
- The five-year high for Work In Process was $286.7 million in Q1 2019, with the low at $286.7 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.15 Bn | 7.50 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 286.71 Mn |